cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.21430/m3nt600qa9
title: Protective activity of mRNA vaccines

description: Although mRNA vaccines encoding the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) prevent COVID-19, the emergence of new viral variants jeopardizes their efficacy. Here, we assessed the immunogenicity and protective activity of historical (mRNA-1273, designed for Wuhan-1 spike protein) or modified (mRNA-1273.351, designed for B.1.351 spike protein) Moderna mRNA vaccines in 129S2 and K18-hACE2 mice.
DOI: 10.21430/m3qepyg5ns
title: SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

description: The recent emergence of the Omicron variant has raised concerns of escape from protection by vaccines and therapeutic antibodies. A key test for potential countermeasures against the variant is their activity in preclinical rodent models of respiratory tract disease. Here, we evaluated the ability of several B.1.1.529 isolates to cause infection and disease in immunocompetent and human ACE2 (hACE2)-expressing mice and hamsters.
DOI: 10.21430/m3dd8r6ri0
title: Structural analysis of COBRA protection

description: Determined the crystal structure of the COBRA HA termed P1 and identified antigenic and glycosylation properties that contribute to its immunogenicity
DOI: 10.21430/m3uybqd3cu
title: Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses

description: To assess the immunogenicity and protective efficacy of nucleoside-modified mRNA-LNP vaccines that contain four influenza A group 2 virus antigens
DOI: 10.21430/m3y1uzjbp5
title: A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice

description: Vaccines targeting SARS-CoV-2 have been shown to be highly effective; however, the breadth against emerging variants and the longevity of protection remains unclear. Postimmunization boosting has been shown to be beneficial for disease protection, and as new variants continue to emerge, periodic (and perhaps annual) vaccination will likely be recommended. New seasonal influenza virus vaccines currently need to be developed every year due to continual antigenic drift, an undertaking made possible by a robust global vaccine production and distribution infrastructure. To create a seasonal combination vaccine targeting both influenza viruses and SARS-CoV-2 that is also amenable to frequent reformulation, we have developed an influenza A virus (IAV) genetic platform that allows the incorporation of an immunogenic domain of the SARS-CoV-2 spike (S) protein onto IAV particles. Vaccination with this combination vaccine elicited neutralizing antibodies and provided protection from lethal challenge with both pathogens in mice. This approach may allow the leveraging of established influenza vaccine infrastructure to generate a cost-effective and scalable seasonal vaccine solution for both influenza and coronaviruses.
DOI: 10.21430/m3qyg9mi3p
title: Multi-subtype protection N1 Vaccination

description: Protection induced by vaccination with the computationally optimized broadly reactive NA antigen (N1-I COBRA NA) was characterized in both influenza serologically naive and pre-immune ferret models following H1N1 viral challenge.
DOI: 10.21430/m3n0yzn1l0
title: Concomitant administration of seasonal influenza and COVID-19 mRNA vaccines

description: The authors aimed to understand the impact of mRNA COVID-19 vaccines administered concomitantly on the immune response to influenza vaccines.
DOI: 10.21430/m3hzi08ozi
title: XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2, HV.1, JN.1 and SARS-CoV-1, but limited XBB.1.5 specific antibodies

description: Here, the investigators assessed sera collected before, 1-month and 3-months following administration of an updated XBB.1.5 monovalent vaccine to individuals with diverse infection and vaccination histories.
DOI: 10.21430/m3dtj2hg1t
title: Robust induction of functional humoral response by a plant-derived Coronavirus-like particle vaccine candidate for COVID-19.

description: To assess the safety, tolerability, and humoral immune response induced by two doses of AS03-adjuvanted and non-adjuvanted plant-derived Coronavirus-like particle (CoVLP) vaccine candidate.
DOI: 10.21430/m3jbpq0sp8
title: Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia

description: To study the kinetics and dynamics of immune response to SARS-CoV-2 infection using primary human air-liquid interface cultures representing the lung broncho-alveolar epithelia.
DOI: 10.21430/m3ofed88wb
title: Targeted electronic health record-based recruitment strategy to enhance COVID-19 vaccine response clinical research study enrollment

description: To evaluate the feasibility of implementing an EHR-based participant identification strategy for rapid recruitment into an observational study during an extended period of restricted in-person clinic visits due to the COVID-19 pandemic.
DOI: 10.21430/m3k6ff5pj2
title: Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions

description: To comprehensively profile the differences in vaccine-induced immunity to BA.1 and BA.2 at three doses of BNT162b2
DOI: 10.21430/m3zj820tce
title: Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence

description: To investigate the concordance of results across four immunoassays targeting different antigens for sera collected at the beginning of the SARS-CoV-2 pandemic in the United States.
DOI: 10.21430/m3lvqbhhqa
title: Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology

description: To investigate whether vaccines adjuvanted with alum and BcfA, delivered through a heterologous prime-pull regimen, provide sustained protection against SARS-CoV-2 infection.
DOI: 10.21430/m30xil800q
title: COVID-19 hospitalization risk after outpatient nirmatrelvir/ritonavir use, January to August 2022, North Carolina

description: To estimate the impact of outpatient nirmatrelvir/ritonavir on COVID-19 hospitalization risk in a US healthcare system.
DOI: 10.21430/m38ay9p4lp
title: Activation of coagulation and proinflammatory pathways in thrombosis with thrombocytopenia syndrome and following COVID-19 vaccination

description: To evaluate the host transcriptomic and proteomic changes following vaccination with Ad26.COV2.S, mRNA-1273, and BNT162b2 COVID-19 vaccines in healthy individuals and in patients who developed thrombocytopenia syndrome (TTS).
DOI: 10.21430/m39fbi6yob
title: Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Inpatient Clinical Outcome

description: To observe the impact of SARS-CoV-2 variants on clinical trajectory and outcome.
DOI: 10.21430/m3udfcjozb
title: An ELISA-Based Method to Measure Mucosal Antibody Responses Against SARS-CoV-2 in Human Saliva

description: To develop and in vitro assay based on the enzyme-linked immunosorbent assay (ELISA) to assess mucosal antibody response to SARS-CoV-2 spike protein in human saliva.
DOI: 10.21430/m3kktygzoh
title: Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults

description: To compare humoral responses to SARS-CoV-2 in infants and young children with the responses in adults.
DOI: 10.21430/m3pbprlthd
title: Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3

description: To characterize two new XBB variants rising in circulation – EG.5.1 and XBB.2.3, for their neutralization and syncytia formation.
DOI: 10.21430/m32m0kzboa
title: Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosis

description: To investigate the roles of the noncanonical inflammasome molecule Caspase-4/11 in promoting pathological inflammatory and prothrombotic pathways in severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2) infections.
DOI: 10.21430/m3gsreonee
title: Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters

description: To evaluate the immunogenicity of the BA.5-containing bivalent mRNA boosters in monovalent and bivalent boosted individuals.
DOI: 10.21430/m3qdai95ry
title: Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants

description: To evaluate JN.1 and its subvariants SLip, FLiRT, and KP.2 for neutralization by sera from vaccinated individuals, SARS-CoV-2-infected patients, or class III mAb S309.
DOI: 10.21430/m3fe995t1c
title: Heterologous versus homologous boosting elicits qualitatively distinct, BA.5-cross-reactive T cells in transplant recipients

description: To investigate BA.5-reactive T cell responses in SOTRs and the impact of boosting with Ad vectored vaccines compared with mRNA, specifically assessing T-cell and Ab responses with a third dose of mRNA or Ad vector following 2 primary doses of mRNA vaccination.
DOI: 10.15468/dl.56gret
title: Occurrence Download

description: A dataset listing the 131 species recorded in GBIF matching the query:
{
 "and" : [
 "BasisOfRecord is one of (Material citation, Specimen)",
 "Country is United Arab Emirates",
 "OccurrenceStatus is Present",
 "TaxonKey is Lepidoptera"
 ]
}

 The dataset's 131 records were derived from 19 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0024640-240906103802322/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.21430/m353ujvxz5
title: Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients

description: To evaluate the following (1) the change in nAb following 300 + 300 mg tixagevimab + cilgavimab injection against Omicron sublineages, including BA.4/5, among fully vaccinated SOTRs and (2) the durability of the neutralizing activity over time.
DOI: 10.21430/m34kdlbcoo
title: Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques

description: To investigate the mechanism of the potency of Ad26 boosting and near-complete protection against SARS-CoV-2 BQ.1.1 challenge in rhesus macaques.
DOI: 10.21430/m383cp13zl
title: mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations

description: To evaluate if any of the components of mRNA-1273 or BNT162b2 formulations elicited PEG-specific antibody responses in serum by enzyme linked immunosorbent assay (ELISA).
DOI: 10.21430/m3p4184a9h
title: Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice

description: To investigate the effects of IFITM3 on SARS-CoV-2 infection of cells, and its impact on viral pathogenesis in vivo.
DOI: 10.21430/m3mywpkniw
title: Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies

description: To investigate the neutralizing activity of full dose AZD7442 against live, contemporary Omicron variants after administration to patients who are immunocompromised.
DOI: 10.21430/m3t7l3epty
title: Continued evasion of neutralizing antibody response by Omicron XBB.1.16

description: To evaluate the evasion of neutralizing antibody response by Omicron XBB.1.16 in comparison with XBB.1.5 variant in vaccinated and convalescent sera.
DOI: 10.21430/m3f42ro93c
title: Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system

description: To assess the relative contributions of SARS-CoV-2 infection and vaccination to population-level SARS-CoV-2 seroprevalence.
DOI: 10.21430/m3lnvqe4he
title: Association of Cytomegalovirus Serostatus With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responsiveness in Nursing Home Residents and Healthcare Workers

description: To determine the association of CMV serostatus and prior SARS-CoV-2 infection with antibody titers after primary and booster BNT162b2 mRNA vaccinations in healthcare workers and nursing home residents.
DOI: 10.21430/m3i2go9mbk
title: Understanding Concerns about COVID-19 and Vaccination: Perspectives from Kidney Transplant Recipients

description: To improve our understanding of the impact of the CVID-19 pandemic and views of vaccinations on kidney transplant recipients.
DOI: 10.21430/m3h0uaez7s
title: Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment

description: To understand whether therapeutic convalescent plasma or control plasma containing endemic human coronavirus (ehCoV) (229E, OC43, NL63, and HKU1) antibodies might alter the outcome of COVID-19 progression to hospitalization
DOI: 10.21430/m34yf8kmq2
title: Anti-PF4 antibodies associated with disease severity in COVID-19

description: To investigate the presence of anti-PF4 antibodies in the serum of patients with COVID-19 and to assess the role of anti-PF4 antibodies in the severe multiorgan disease manifestations in patients with severe COVID-19.
DOI: 10.21430/m3uxchocpn
title: Minding the margins: Evaluating the impact of COVID-19 among Latinx and Black communities with optimal qualitative serological assessment tools

description: To reveal the impact of COVID-19 and vaccine uptake among diverse communities and to develop rigorous serological downstream evaluation methods.
DOI: 10.21430/m3kpxqbm7d
title: Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity

description: To comprehensively profile the Fc landscape of mRNA-induced humoral immune responses across a cohort of individuals who had previously experienced COVID-19 or were infection-naïve.
DOI: 10.21430/m3fgea29gm
title: Nasally delivered interferon lambda protects mice against SARS-CoV-2 infection

description: IFN-l protects against SARS-CoV-2 B.1.351 (Beta) and B.1.1.529 (Omicron) variants in three strains of mice
DOI: 10.21430/m38bq3hjwl
title: Sialylated IgG-induced RE1-Silencing Transcription Factor (REST) protects against lung inflammation and severe influenza disease

description: In this study, the investigators address how Fc glycosylation on endogenously produced anti-influenza IgG impacts influenza immunity.
DOI: 10.21430/m33wc6jlyp
title: Modeling in higher dimensions to improve diagnostic testing accuracy: Theory and examples for multiplex saliva-based SARS-CoV-2 antibody assays

description: To address the shortcomings of confidence intervals and receiver operating characteristics in conventional classification strategies by examining high-dimensional mathematical models.
DOI: 10.5281/zenodo.13751415
title: Data for "Impact of the Out-of-Plane Flow Shear on Magnetic Reconnection at the Flanks of Earth's Magnetopause"

description: Data for Figures 3-8 in the paper. The data is compatible with all data-analysis software. Here are the guidelines for reading and visualizing the data:

(1) The filenames "noshear", "MA0p7", and "MA2p3" correspond to the simulation runs with no flow shear, Mach number M_A=0.7 flow shear, and M_A=2.3 flow shear.

(2) The "upper" and "lower" mean upper and lower current sheet, corresponding to dusk-side and dawn-side reconnection respectively. For the "noshear" case, only the "upper" is considered.

(3) Each data file (*.dat) is written in ASCII format and has multiple columns. The first row is the header.



The first column is always the x-coordinates of the figure. 

For the line plots, all columns starting from the second column are the y-coordinates for different variables. The variables names can be found at the header. 

For the 2D image plots, the second column is the y-coordinates, and the third column is the value of the variable at a given (x,y) location. 


(4) The files "fig4_*_field_*.dat" are the magnetic potential in the x-y domain. The contour of this potential gives the in-plane field line configurations.
DOI: 10.5281/zenodo.13221941
title: Data for "Impact of the Out-of-Plane Flow Shear on Magnetic Reconnection at the Flanks of Earth's Magnetopause"

description: Data for Figures 3-8 in the paper (data for Figures 5 has been updated on 2024-09-20). The data is compatible with all data-analysis software. Here are the guidelines for reading and visualizing the data:

(1) The filenames "noshear", "MA0p7", and "MA2p3" correspond to the simulation runs with no flow shear, Mach number M_A=0.7 flow shear, and M_A=2.3 flow shear.

(2) The "upper" and "lower" mean upper and lower current sheet, corresponding to dusk-side and dawn-side reconnection respectively. For the "noshear" case, only the "upper" is considered.

(3) Each data file (*.dat) is written in ASCII format and has multiple columns. The first row is the header.



The first column is always the x-coordinates of the figure. 

For the line plots, all columns starting from the second column are the y-coordinates for different variables. The variables names can be found at the header. 

For the 2D image plots, the second column is the y-coordinates, and the third column is the value of the variable at a given (x,y) location. 


(4) The files "fig4_*_field_*.dat" are the magnetic potential in the x-y domain. The contour of this potential gives the in-plane field line configurations.
DOI: 10.5281/zenodo.13221942
title: Data for "Impact of the Out-of-Plane Flow Shear on Magnetic Reconnection at the Flanks of Earth's Magnetopause"

description: Data for Figures 3-8 in the paper. The data is compatible with all data-analysis software. Here are the guidelines for reading and visualizing the data:

(1) The filenames "noshear", "MA0p7", and "MA2p3" correspond to the simulation runs with no flow shear, Mach number M_A=0.7 flow shear, and M_A=2.3 flow shear.

(2) The "upper" and "lower" mean upper and lower current sheet, corresponding to dusk-side and dawn-side reconnection respectively. For the "noshear" case, only the "upper" is considered.

(3) Each data file (*.dat) is written in ASCII format and has multiple columns. The first row is the header.



The first column is always the x-coordinates of the figure. 

For the line plots, all columns starting from the second column are the y-coordinates for different variables. The variables names can be found at the header. 

For the 2D image plots, the second column is the y-coordinates, and the third column is the value of the variable at a given (x,y) location. 


(4) The files "fig4_*_field_*.dat" are the magnetic potential in the x-y domain. The contour of this potential gives the in-plane field line configurations.
DOI: 10.5281/zenodo.13751421
title: Data for "Impact of the Out-of-Plane Flow Shear on Magnetic Reconnection at the Flanks of Earth's Magnetopause"

description: Data for Figures 3-8 in the paper (data for Figures 5 and 8 has been updated on 2024-09-12). The data is compatible with all data-analysis software. Here are the guidelines for reading and visualizing the data:

(1) The filenames "noshear", "MA0p7", and "MA2p3" correspond to the simulation runs with no flow shear, Mach number M_A=0.7 flow shear, and M_A=2.3 flow shear.

(2) The "upper" and "lower" mean upper and lower current sheet, corresponding to dusk-side and dawn-side reconnection respectively. For the "noshear" case, only the "upper" is considered.

(3) Each data file (*.dat) is written in ASCII format and has multiple columns. The first row is the header.



The first column is always the x-coordinates of the figure. 

For the line plots, all columns starting from the second column are the y-coordinates for different variables. The variables names can be found at the header. 

For the 2D image plots, the second column is the y-coordinates, and the third column is the value of the variable at a given (x,y) location. 


(4) The files "fig4_*_field_*.dat" are the magnetic potential in the x-y domain. The contour of this potential gives the in-plane field line configurations.
DOI: 10.15468/dl.4jdgs2
title: Occurrence Download

description: A dataset containing 6587 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Belize",
 "OccurrenceStatus is Present",
 "TaxonKey is Squamata",
 "Year 1961-2024"
 ]
}

 The dataset includes 6587 records from 34 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0024645-240906103802322/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5519/qd.3urprzkn
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (53 records)
DOI: 10.5519/qd.54b2ooq4
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (4 records)
DOI: 10.15468/dl.em8n84
title: Occurrence Download

description: A dataset containing 1299199 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Continent is Europe",
 "Country is Sweden",
 "TaxonKey is Cyperaceae"
 ]
}

 The dataset includes 1299199 records from 174 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0024634-240906103802322/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.mgujuh
title: Occurrence Download

description: A dataset containing 12087 species occurrences available in GBIF matching the query:
{
 "and" : [
 {
 "or" : [
 "TaxonKey is Acer saccharum Marshall"
 ]
 },
 "HasCoordinate is TRUE",
 "Year is greater than or equal to 2010",
 "Year is less than or equal to 2020",
 "DecimalLatitude is greater than or equal to 24.1271113347408",
 "DecimalLatitude is less than or equal to 56.572699215132005",
 "DecimalLongitude is greater than or equal to -89.31544323258166",
 "DecimalLongitude is less than or equal to -51.73636965516586",
 "OccurrenceStatus is Present"
 ]
}

 The dataset includes 12087 records from 61 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0024648-240906103802322/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.c2mtee
title: Occurrence Download

description: A dataset containing 544 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Periploca angustifolia Labill."
 ]
}

 The dataset includes 544 records from 29 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0024649-240906103802322/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.8wkbdq
title: Occurrence Download

description: A dataset containing 1262559 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Continent is Europe",
 "Country is Germany",
 "TaxonKey is Cyperaceae"
 ]
}

 The dataset includes 1262559 records from 594 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0024635-240906103802322/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.srxy86
title: Occurrence Download

description: A dataset containing 4 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Cephalotes foliaceus (Emery, 1906)"
 ]
}

 The dataset includes 4 records from 3 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0024650-240906103802322/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.